Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Takara Bio Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Register your interest

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
17 Oct 2022 Takara Bio USA and BioExcel Diagnostics Enter into Partnership Partnership -
BioExcel Diagnostics  

Takara Bio USA Inc  

21 Jun 2021 BioNTech Cell & Gene Therapies Enter into Licensing Agreement with Takara Bio Licensing Agreement
BioNTech Cell & Gene Therapies GmbH  

Takara Bio Inc
31 Dec 2020 Takara Bio Enters into Agreement with Mie University Faculty of Medicine Partnership -
Mie University Graduate School / Faculty of Medicine  

Takara Bio Inc
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Register your interest
Get in touch about GlobalData Explorer

Contact the team or request a demo to find out how our data can drive your business forward

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer